
    
      This study will assess whether a calcineurin inhibitor (CNI)-free regimen with everolimus and
      mycophenolic acid is associated with a better renal outcome as compared to the standard
      regimen containing cyclosporine A (which belongs to the class of CNIs) and everolimus; while
      both treatments are expected to be comparable with respect to efficacy.
    
  